
Journal of Medicinal Chemistry p. 1084 - 1104 (2020)
Update date:2022-08-15
Topics:
Kurasawa, Osamu
Miyazaki, Tohru
Homma, Misaki
Oguro, Yuya
Imada, Takashi
Uchiyama, Noriko
Iwai, Kenichi
Yamamoto, Yukiko
Ohori, Momoko
Hara, Hideto
Sugimoto, Hiroshi
Iwata, Kentaro
Skene, Robert
Hoffman, Isaac
Ohashi, Akihiro
Nomura, Toshiyuki
Cho, Nobuo
In our pursuit of developing a novel, potent, and selective cell division cycle 7 (Cdc7) inhibitor, we optimized the previously reported thieno[3,2-d]pyrimidinone analogue I showing time-dependent Cdc7 kinase inhibition and slow dissociation kinetics. These medicinal chemistry efforts led to the identification of compound 3d, which exhibited potent cellular activity, excellent kinase selectivity, and antitumor efficacy in a COLO205 xenograft mouse model. However, the issue of formaldehyde adduct formation emerged during a detailed study of 3d, which was deemed an obstacle to further development. A structure-based approach to circumvent the adduct formation culminated in the discovery of compound 11b (TAK-931) possessing a quinuclidine moiety as a preclinical candidate. In this paper, the design, synthesis, and biological evaluation of this series of compounds will be presented.
View More
Anhui Asahikasei Chemical Co., Ltd
Contact:86-551-4259770
Address:No. 88 Linquan Road Hefei Anhui China
Jinan Decheng Hemu Medical Technology Co.,Ltd.
Contact:+86-531-68650525
Address:NO.554 Zhengfeng Road High-new Technology Development Zone
Qingdao Kylin Trading Co., Ltd.
Contact:0086-532-68979884/58972912/68972263/65/88171519
Address:Room 2308,A building International Trade Center No.230 Changjiang Middle Road of Qingdao Economic Development Zone,Shandong,China.
ZHEJIANG JIANYE CHEMICAL CO.,LTD.
Contact:86-571-64149273,64149234
Address:No. 48, Fuxi Road, Meicheng Town
Shenzhen Sunrising Industry Co., ltd.
Contact:+86 755 86571158 / 86571159 / 86571160
Address:2108 ZHENYE INT. BUSINESS CENTER,NO.3101-90 QIANHAI RD, NANSHAN,SHENZHEN, CHINA
Doi:10.1246/bcsj.62.3691
(1989)Doi:10.1007/BF00912610
(1974)Doi:10.1016/S0040-4020(01)91019-1
(1991)Doi:10.1021/acs.orglett.7b04042
(2018)Doi:10.1021/jacs.9b11601
(2019)Doi:10.1002/jlac.197419740208
(1974)